Drug Profile
R-fluoxetine
Latest Information Update: 24 Oct 2000
Price :
$50
*
At a glance
- Originator Sepracor
- Class Antidepressants
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 24 Oct 2000 Discontinued-II for Depression in USA (PO)
- 01 May 2000 Federal Trade Commission concludes review of Sepracor-Eli Lilly and Company agreement in April 2000
- 12 Jan 1999 Phase-II clinical trials for Depression in USA (PO)